Phytochemical Name : Rocaglaol

Properties Information
PhytoCAT-ID PhytoCAT-0
Phytochemical name or plant extracts Rocaglaol
PMID 16619491
Literature evidence It exhibited in vitro cytotoxic activity against Lu1, LNCaP and MCF-7 cells with ED50 values of 13.8, 23.0 and 9.2 nM, respectively.
IUPAC name (1R,3S,3aR,8bS)-6,8-dimethoxy-3a-(4-methoxyphenyl)-3-phenyl-2,3-dihydro-1H-cyclopenta[b][1]benzofuran-1,8b-diol
Phytochemicals’ class or type of plant extracts Cyclopenta[b]benzofuran
Source of phytochemicals or plant Extracts Aglaia crassinervia
Geographical availability Borneo, Malaya, Myanmar, Nicobar Is., Philippines, Sumatera, Thailand, Vietnam
Plant parts Bark
Other cancers Breast cancer, Prostate cancer, Colorectal cancer, Leukemia, Liver cancer, Lung cancer
Target gene or protein Bax, Bcl-xL, Caspase 9, Caspase 7, Cdc25c
Gene or Protein evidence Rocaglaol treatment induced Bax expression through 12 to 72 h of exposure, while Bcl-xl expression was slightly decreased through 48 h, and decreased more significantly by 72 h. Cleaved caspase-9 expression was detected at 72 h, and cleaved caspase-7 was increased through 48 to 72 h. In addition, protein phosphatase Cdc25C, which functions as a mitotic activator by dephosphorylation of Cdc2, decreased in a time-dependent manner after rocaglaol treatment.
Target pathways Mitochondrial pathway
IC50 0.008 µM against MCF-7
Potency Rocaglaol is a cytotoxic cyclopenta[b]benzofuran isolated from the bark of Aglaia crassinervia. It exhibited in vitro cytotoxic activity against Lu1, LNCaP and MCF-7 cells with ED50 values of 13.8, 23.0 and 9.2 nM, respectively. In summary, the data presented in this study indicate that rocaglaol is a potent cytotoxic agent that induces cell cycle arrest at the G2/M-phase and apoptosis through the mitochondrial pathway
Cell line/ mice model Lu1, LNCaP, HL-60, SMMC-7721, A-549, MCF-7, W480
Additional information  NA
PubChem ID 393602
Additional PMIDs 25742723
Additional sources of information https://powo.science.kew.org/taxon/577033-1
Safety NA